OXYBUTYNIN CHLORIDE
- Product NDC
- 50090-8078
- 11-digit product format
- 500908078
- Labeler code
- 50090
- Product ID
- 50090-8078_0fe86fc9-7a70-4911-9567-74da2b585e75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXYBUTYNIN CHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA209025
- Marketing category
- ANDA
- Marketing start
- 2026-04-27
- Substance
- OXYBUTYNIN CHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209025-001 | OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | |
| A209025-002 | OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | AB | RS | 2023-02-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209025-001 | AB |
| A209025-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | AB | RS | 2023-02-07 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | AB | RS | 2023-02-07 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209025-002 | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET / ORAL | RS | 2023-02-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A209025-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-21 | 5aa47cf7b7d7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209025-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209025-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209025-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209025-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209025-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209025-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209025-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209025-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209025-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209025-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209025-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209025-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209025-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209025-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209025-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209025-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209025-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209025-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209025-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209025-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209025-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209025-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A209025-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209025-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209025-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A209025-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A209025-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A209025-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A209025-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A209025-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A209025-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209025-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A209025-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A209025-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209025-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209025-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209025-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209025-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A209025-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A209025-001 | AB | 1 | 3bdfa0b2c4d7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OXYBUTYNIN CHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXYBUTYNIN CHLORIDE | 5 mg/1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | 9578b6b8-5b9d-4263-9142-39b2c7216b85 | 2026-07-21 | Warnings, Adverse reactions | 209025 ANDA209025 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 44990ed6-b8e7-40f5-b636-e848024ec6d8 | 2025-11-18 | Warnings, Adverse reactions | 209025 ANDA209025 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 0697b3cf-b146-47c0-b5a5-5905ae8d1c97 | 2025-11-18 | Warnings, Adverse reactions | 209025 ANDA209025 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2025-08-18 | Warnings, Adverse reactions | 209025 ANDA209025 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3a319017-4e25-402e-8ba0-63b9f1eb707e | 2025-02-27 | Warnings, Adverse reactions | 209025 ANDA209025 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f26e590d-956e-493b-a6ac-6056aeeaf411 | 2024-08-09 | Warnings, Adverse reactions | 209025 ANDA209025 |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | f8ed80f2-6c3d-4d7f-b761-c2447973c1f9 | 2024-07-03 | Warnings, Adverse reactions | 209025 ANDA209025 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-8078-0 | 50090807800 | 30 TABLET in 1 BOTTLE (50090-8078-0) | 30 tablet | 2026-09-16 | No | No | Current |
| 50090-8078-1 | 50090807801 | 100 TABLET in 1 BOTTLE (50090-8078-1) | 100 tablet | 2026-09-16 | No | No | Current |
| 50090-8078-3 | 50090807803 | 90 TABLET in 1 BOTTLE (50090-8078-3) | 90 tablet | 2026-09-16 | No | No | Current |